议程| MedTech World北美

申请成为演讲者

11 周一

12 周二

13 周三

10:00 – 12:00

文化之旅

从佛罗里达生活方式体验开启我们的大会。乘坐全新双体帆船，在水上享受棕榈滩的美景与魅力，全程 120 分钟的娱乐巡游。

仅限白金票（Platinum Ticket）持有者专享。

14:00 – 16:30

MedTech World 投资人专属论坛

仅限申请参加地点：西棕榈滩希尔顿酒店 Capony 餐厅

投资者专属论坛的参与资格严格限定于活跃的医疗科技（MedTech）生态系统投资者。符合条件的参与者包括：

风险投资公司（Venture Capital Firms）

天使投资人（Angel Investors）

家族办公室（Family Offices）

企业风险投资部门（Corporate Venture Arms）

医院投资代表（Hospital Investment Representatives）

所有参与者必须持有有效的会议通行证。每份申请将由 MedTech World 团队审核，并根据上述标准决定是否批准。

14:00 – 16:30

MedTech World 首席执行官专属论坛

仅限申请参加地点：西棕榈滩希尔顿酒店 Capony 餐厅

CEO 专属论坛的参与资格严格限定于活跃医疗器械初创公司的现任首席执行官。所有参与者必须持有有效的会议通行证。每份申请将由 MedTech World 团队审核，并根据上述标准决定是否批准。

17:30 – 20:30

预注册接待

预注册及社交招待会

面向所有票种持有者由 CS Lifesciences 与 MedTech World 联合赞助

地点：西棕榈滩希尔顿酒店 Mezze 餐厅

19:30 – 23:00

MedTech World 大奖

MedTech World 美国大奖将标志着我们在美国举办的首届颁奖典礼，旨在表彰医疗科技与健康科技领域的卓越与创新。大会将嘉奖初创企业、投资者、临床专家以及生态系统建设者，突出那些推动医疗进步的个人与机构。此次里程碑式活动由 Blue Goat Cyber 赞助，将在真正的全球舞台上彰显 MedTech 领导力。颁奖典礼将在西棕榈滩希尔顿酒店 Oceana 宴会厅举行。仅限白金票（Platinum Ticket）持有者入场，且需提前 RSVP。

08:00 – 18:00

会议第一天

本次议程专为 2026 年的行动而设计，涵盖：如何在大型医疗体系中取得成功、如何应对市场准入与监管准备、如何筹集资本并规划成果、如何与战略合作伙伴及医疗系统建立合作，以及如何捕捉下一波机器人技术、女性健康、神经科学和新兴医疗器械的突破性创新浪潮。大会将以现场初创企业路演竞赛收官，届时一批精心挑选的团队将登台展示，并在投资人评审团面前进行评审。

09:00 – 09:05 / Opening Address

Dr. Dylan Attard

首席执行官兼创始人

MedTech World

09:05 – 09:15 / Opening Keynote

His Excellency Dr Godfrey C. Xuereb

马耳他共和国驻美国大使

Embassy of the Republic of Malta

09:20 – 10:00 / Cracking the Enterprise Health System: How to Sell and Scale in 2026

A discussion on what it really takes for startups and innovators to break into large health systems in 2026. Leaders from health systems, legal, and policy will share how procurement decisions are made, what buyers actually look for, and how companies can navigate pilots, partnerships, and scale.

Wael Barsoum

总裁兼首席转型官

Healthcare Outcomes Performance Company (HOPCo)

George Stephen LeMieux

董事会主席

Gunster

Dr. Dipen J Parekh

首席执行官兼执行副总裁

University of Miami Health System, UHealth, Health Affairs at the University of Miami

Mary C. Mayhew

总裁兼首席执行官

Florida Hospital Association

Cody Simmons

Co-Founder & CEO

DermaSensor Inc

10:00 – 10:40 / Unlocking US Market Access: Regulatory, Reimbursement & Your First Customers

This panel will explore what it really takes to enter and grow in the US market, from navigating regulatory pathways and reimbursement strategy to securing your first commercial customers. Speakers will share practical insights on how startups can align clinical, regulatory, and go to market planning early to avoid costly delays and build a stronger path to adoption.

Blythe Karow

Founder & Principal

The Karow Advisory Group

Angela Paterson

首席顾问

CS Life Sciences

Mercè Guerra

Associate Director, Regulatory Affairs Medtech

Alira Health

Danielle E. Sapega

Member

Cozen O'Connor

Dr. Jose Osorio

Electrophysiologist, Founder, Strategic Advisor, and Managing Partner

3PH Alliance | NuPulse Capital

10:40 – 11:15 / Company Showcases

Farrukh Usman

创始人兼首席执行官

Byonyks

Rigu Gupta

CEO

PIROGON, Inc

Andreas Forsland

创始人兼首席执行官

Cognixion

Reginald Allouche

CEO and co-founder

Paltech

11:15 – 11:25 / Keynote

Rajit Kamal

Vice President and General Manager, Surgical Robotics

Medtronic

11:25 – 12:05 / Hospital Venture Funds: Where Capital Meets Clinical Innovation

Hospital venture funds provide more than capital, offering startups clinical access, validation pathways, and strategic partnerships. This panel explores how these investors work with founders through pilots, co-development, and collaborations with other VCs.

Alex Condon

首席运营官

Matrix One

Anita Watkins

常务董事

Rex Health Ventures / UNC Health

Sibo Gama Morales

Investment Associate

Orlando Health Ventures

Todd Schwarzinger, MBA

Partner, Innovations Ventures

Cleveland Clinic Innovations

Patrick Wayte

SVP, Center for Health Technology & Innovation

American Heart Association

12:05 – 13:10 / Lunch Break

13:10 – 13:50 / Where the Smart Money Is Going: A Frank Look at MedTech Capital in 2026

This panel explores where investors are placing capital in MedTech in 2026, what themes are attracting the strongest interest, and what makes companies stand out in a more selective funding environment. Speakers will share a candid perspective on how capital is being deployed, which sectors are gaining attention, and what founders need to understand to raise successfully in today’s market.

Steven Levy

Partner

Unorthodox Ventures

Greg Madden

执行合伙人

SV Health Investors

Chris Japp

合伙人

Tramway Ventures

Sid Arora

Vice President, Healthcare Investment Banking

Ernst & Young Capital Advisors

Eric Tansky

Head of Medical Technology Banking

Oppenheimer & Co. Inc.

13:55 – 14:05 / Keynote " From Family Enterprise to Strategic Partnership: The NAMSA Journey"

John Gorski

Vice Chair, Board of Directors (former CEO)

NAMSA

14:05 – 14:45 / Surgical Robotics & Smart ORs for Mid-Sized Hospitals

Moving from prestige robots to practical, cost-effective platforms; financing models (leasing, per-use).

Manish Chand

机器人外科医生兼技术研究员

University college London

Yathart Gupta

战略财务总监（FP&A）

Karl Storz

Dr David Laith Rawaf

临床总监 / 临床战略与合作伙伴关系负责人

VitVio

Rachna Dayal

管理合伙人

Sugati Ventures

Rajit Kamal

Vice President and General Manager, Surgical Robotics

Medtronic

14:45 – 15:30 / Commercialization Playbook for MedTech Startups: From Readiness to Revenue

A successful commercialization strategy can make or break a MedTech startup. This panel will dive into how founders can prepare for market entry, avoid common pitfalls, and build the right foundations for adoption, revenue, and long term scale.

Ivanny Franklin

管理合伙人

MedSight Capital

Maunark S Patel

Co-Founder, CEO

Skuvent Inc

Tim Lawrie

Founder and CEO

ProjectUS Consulting

Claudia Holy

创始人兼首席执行官

Podymos Ltd

Joe Sasson

Chief Commercial Officer and EVP, MedAxiom Ventures

MedAxiom

15:30 – 16:00 / Company Showcases

Presenting Slot

Murthy Anupindi

Co-Founder

ComplyWise

Siddarth Nandyala

Founder & CEO

Circadian AI

Manish Wadhwa MD FHRS FACC FESC

Chief Executive Officer

SummaCor

16:05 – 16:45 / Women’s Health Devices: Beyond Fertility & Pregnancy

Underfunded but fast-growing: menopause, pelvic floor, oncology; how to build and commercialize in this space.

Desert Horse Grant

lead of innovation

Sylvester Comprehensive Cancer Center

Addie Harris

合伙人

Precision Life Science Partners

Thorsten Waloschek

首席执行官

NeoPredics

Darshana Zaveri

Founder & Managing Partner

Catalyst Health Ventures (CHV)

Dr. Ashraf Affan

Founder & CEO

Angel Kids Pediatrics and Behavioral Health

16:45 – 17:25 / From Hospital to Home: The Cardio Care Continuum

How cardio care is moving beyond the hospital through remote monitoring, integrated care pathways, and reimbursement-ready models that connect health systems, innovators, and partners.

Christina J. Wurster

Chief Executive Officer

Heart Rhythm Society

Maulik Majmudar

首席医疗官

Biofourmis

Dr. David Albert

创始人兼首席医疗官

AliveCor

Homer Quintana

医疗器械快速转化中心主任

Houston Methodist

Ken Nelson

合伙人

MedTech Advantage Fund

17:25 – 17:30 / Closing Remarks

Yulia Yurevich

客户关系与战略合作负责人

MedTech World

12:00 – 13:00 / FDA, Payers & Hackers: The Three Forces That Make or Break a Launch

Invite Only

Christian Espinosa

CEO

Blue Goat Cyber

Edwin Lindsay

董事总经理

CS Lifescience

Lori Ellis

Host

Open Door Salon

19:30 – 23:00

晚间 VIP 社交招待会

晚间 VIP 社交招待会，此次晚宴由 Blue Goat Cyber 赞助，仅限白金通行证（Platinum Access）持有者参加，将在佛罗里达州西棕榈滩 IL Bellagio 意大利餐厅举行。

招待会将提供一个亲密的高层交流环境，便于投资者、首席执行官及行业领袖进行高质量网络互动。伴随着佛罗里达充满活力的风景，当晚将融合精致的款待与战略性对接，促进推动未来合作的有意义关系。这里，将真正开启塑造医疗科技下一篇章的关键对话。

09:00 – 18:00

会议第二天

09:00 – 09:40 / Strategic Money, Strategic Risk: What Corporate Venture Really Wants from MedTech

This panel explores how corporate venture investors evaluate MedTech opportunities through both a financial and strategic lens. Speakers will discuss what makes a company attractive to corporate capital, how strategic priorities shape investment decisions, and where startups often misunderstand the expectations, risks, and opportunities that come with this type of investor.

Matt Henriksson, CFA

Senior Equity Analyst

Bloomberg Intelligence

Komeil Nasrollahi

创新与风险投资合作高级总监

Siemens Healthineers

Dr. Steven Mickelsen

Founder & CTO

Field Medical, Inc.

Mayank Vijayvergia

Head of Strategy, Cardiovascular and Interventional Solutions

GE Healthcare

09:40 – 10:20 / Scaling Neuro Innovation: Capital, Clinical Adoption & Corporate Pathways

As neurotech moves from early validation to market scale, success demands aligning capital, clinical evidence, corporate partnerships, and security — the new non-negotiables for health system trust. This panel unpacks what founders must build now to close deals and attract strategic capital in 2026.

Paula Rutledge

Founder & CEO

Legacy MedSearch

Christian Espinosa

CEO

Blue Goat Cyber

Kip Roberts

副总裁 — 神经科学并购与战略

Medtronic

Brad Maruca

执行董事

Deloitte

Edward Ruppel

Founder, General Partner

Ground Effect Ventures

10:25 – 11:05 / What Breaks MedTech Timelines

MedTech timelines are often delayed not by technology, but by gaps in regulatory planning, clinical execution, and reimbursement strategy. This panel examines the common pitfalls that derail progress and how founders, advisors, and partners can better anticipate and manage the risks that slow innovation.

Joseph Panetta

Chief Marketing Officer

Ascend CRO

Lynn Carney

代理与合作联盟总监

Medmarc

Lian Cunningham

VP Clinical Affairs

Endogenex

Mark Swanson

合伙人

QRx Partners

Charles Dunham

Shareholder

Greenberg Traurig, LLP

11:05 – 11:55 / Company Showcases

Codi Gharagouzloo, Ph.D.

Scientific Founder & CSO

Imaginostics, Inc.

Carlos Granada

CEO

Zelery Med-Corporation

Mark Khachaturian PhD

CEO

Wellvii

Oren Gelman

President & CEO

Arthrolense

Marc Mackey

CEO

PolarisAR

Irena King, PhD

Founder and CEO

Surgicure Technologies

11:55 – 12:30 / 扩大神经创新规模：资金、临床应用和企业发展路径

随着神经科技从早期验证走向市场规模化，成功需要协调资本、临床证据、企业合作和网络安全——这些都是赢得医疗系统信任的全新不可或缺的要素。本次研讨会将深入探讨创始人现在必须构建哪些要素，才能在2026年达成交易并吸引战略资本。

Maryam Mokhtarzadeh

Chief Medical Officer

Persephoni

Karl Mehta

Partner

Mehta Family Offiice

David Snow

Executive Director

Pegasus Park

Boris Reznik

Chairman & CEO

Immorta Bio

Aubry Tandjeu

Medtech Business Consultant

BiB Consulting

12:30 – 13:30 / Lunch Break

13:30 – 14:10 / Exit by Design: How the Best MedTech Companies Engineer Their Acquisition

Premium medtech exits aren’t lucky — they’re built. This panel brings together acquirers, investors, and dealmakers to decode what separates the companies that command competitive offers from those that don’t. From early product decisions to due diligence readiness, attendees will leave with a clearer map of what “exit-ready” actually looks like.

Cale Garverick

Managing Director

TD Cowen

Tripp Higgins

Founder | Chairman

Pacemate

Tasneem Dohadwala

创始合伙人

Excelestar Ventures

Rachel Knutton

CEO/Founder

Alluvia Studio

Oren Gelman

President & CEO

Arthrolense

14:10 – 14:45 / Beyond the Algorithm — How AI is Being Built, Powered & Deployed in Healthcare

AI in healthcare is no longer a question of if — it’s a question of how. This panel goes behind the technology to examine what it actually takes to build clinical-grade AI, power it at scale, and get health systems to deploy it. From validation and trust to compute infrastructure and enterprise adoption, four leaders from across the stack share what the industry is still getting wrong — and what getting it right looks like.

Hawkins C. Gay, MD, MPH, MSAI

Cardiac Electrophysiologist

Northwestern Medicine, Bluhm Cardiovascular Institute

Sam Seder

Chief Growth Officer

Giga Energy

Joshua M. Lampert, MD, FACC

Cardiac Electrophysiologist & Medical Director of Machine Learning

Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai

Dr. Zahra Timsah

Chief Executive Officer

i-GENTIC AI

14:45 – 15:25 / The Florida Advantage: Capital, Clinical & Commercial Strength

Florida is emerging as a powerful force in U.S. MedTech, backed by strong healthcare capital, leading clinical institutions, and real commercial scale. This panel explores why the state is becoming a serious and competitive innovation hub in its own right.

Abby Lindenberg

CEO and Founder

caa

Andrew S. Duffell

总裁

Research Park at Florida Atlantic University

Mark Glickman

President & CEO

BioFlorida, Inc.

Paul Evans

Associate Vice President of External Affairs

Max Planck Florida Institute for Neuroscience

Dr. Barry T. Katzen, MD

Chief Medical Innovation Officer, Founder & Chief Medical Executive Emeritus

Baptist Health South Florida, Miami Cardiac & Vascular Institute

15:30 – 16:00 / Follow the Money: MedTech Equities, Trends & Capital Market Forces

This fireside will take a capital markets lens to the current MedTech landscape, covering the trends reshaping business models across the sector, the investment outlook for global MedTech equities, and the key considerations driving decisions in today’s market environment. With perspectives from Goldman Sachs, Google, and HSBC, it’s set to be one of the sharper conversations of the conference.